门诊与日间延长恢复机器人肝切除术:307例多国研究
该研究审计了2个国家6个肝胆中心2013年至2023年的307例门诊机器人肝切除术(26例当日出院、281例次日出院),以检验机器人入路可成为安全有效的短住院手术这一假设。结果为无死亡、6例并发症(2%)、5例再入院(1.6%),268例恶性肿瘤中25例(9%)为R1切除。
要点
- 307例门诊机器人肝切除术中无死亡,并发症6例(2%),再入院5例(1.6%)。
- 268例恶性肿瘤中R1切除25例(9%);128例上段肝切除中切缘阳性12例(9%)。
- 作者结论认为,经充分选择的病例行门诊机器人肝切除术是安全的。
核心结论
- 作者结论认为,在充分选择的病例中,门诊机器人肝切除术是安全的(死亡率0、并发症2%、再入院1.6%),包括非关节腹腔镜器械难以处理的上段或后段肝切除。
研究设计与样本
- 研究为多国审计,覆盖2个国家6个肝胆中心,纳入2013年至2023年的307例门诊(少于2个午夜)机器人肝切除术。
- 所有站点均开展加速康复外科项目,其中1家机构可提供家庭数字监测。
主要发现
- 307例中26例当日出院、281例次日出院;手术范围包括194例单段、90例双段、14例三段和8例四段肝切除。
- 良性组织学39例(13%),恶性肿瘤268例(其中肝细胞癌33例、胆道癌27例、转移性疾病208例)。
- 患者中位年龄60岁(18至93岁),男性55%,中位BMI 26 kg/m²(14至63 kg/m²),肝硬化30例(10%),既往腹部手术史187例(61%)。
- 中位手术时间163分钟(30至433分钟),中位出血量50 mL(10至900 mL);无死亡,并发症6例(2%):伤口感染2例、发育不良1例、肝周脓肿3例;再入院5例(1.6%)。
- 268例恶性肿瘤中R1切除25例(9%);128例上段(7、8、4A、2、1段)切除中切缘阳性12例(9%),因脓肿再入院2例。
临床怎么用
- 原文结论认为,在充分选择的病例中门诊机器人肝切除术是安全的,可覆盖非关节腹腔镜器械难以处理的上段或后段肝切除。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For open minor hepatectomy, morbidity and recovery are dominated by the incision. The robotic approach may transform this "incision dominant procedure" into a safe outpatient procedure. STUDY DESIGN: We audited outpatient (less than 2 midnights) robotic hepatectomy at 6 hepatobiliary centers in 2 nations to test the hypothesis that the robotic approach can be a safe and effective short-stay procedure. Establishing early recovery after surgery programs were active at all sites, and home digital monitoring was available at 1 of the institutions. RESULTS: A total of 307 outpatient (26 same-day and 281 next-day discharge) robotic hepatectomies were identified (2013 to 2023). Most were minor hepatectomies (194 single segments, 90 bi-segmentectomies, 14 three segments, and 8 four segments). Thirty-nine (13%) were for benign histology, whereas 268 were for cancer (33 hepatocellular carcinoma, 27 biliary, and 208 metastatic disease). Patient characteristics were a median age of 60 years (18 to 93 years), 55% male, and a median BMI of 26 kg/m 2 (14 to 63 kg/m 2 ). Thirty (10%) patients had cirrhosis. One hundred eighty-seven (61%) had previous abdominal operation. Median operative time was 163 minutes (30 to 433 minutes), with a median blood loss of 50 mL (10 to 900 mL). There were no deaths and 6 complications (2%): 2 wound infections, 1 failure to thrive, and 3 perihepatic abscesses. Readmission was required in 5 (1.6%) patients. Of the 268 malignancy cases, 25 (9%) were R1 resections. Of the 128 with superior segment resections (segments 7, 8, 4A, 2, and 1), there were 12 positive margins (9%) and 2 readmissions for abscess. CONCLUSIONS: Outpatient robotic hepatectomy in well-selected cases is safe (0 mortality, 2% complication, and 1.6% readmission), including resection in the superior or posterior portions of the liver that is challenging with nonarticulating laparoscopic instruments.
引用
- Park JO, Lafaro K, Hagendoorn J, et al. Outpatient and Ambulatory Extended Recovery Robotic Hepatectomy: Multinational Study of 307 Cases. J Am Coll Surg. 2024. PMID: 38770933. doi:10.1097/XCS.0000000000001107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。